Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD)

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01675414
Collaborator
Autism Speaks (Other), Columbia University (Other)
131
1
29
4.5

Study Details

Study Description

Brief Summary

The purpose of this research study is to help us learn if children with Autism Spectrum Disorder (ASD) have gastrointestinal (stomach and intestine) problems more frequently than children without ASD do. The investigators hope to learn if children with ASD and gastrointestinal (GI) disorders have certain Problem Behaviors (PB), such as self-injury and aggression, more than children with ASD but no GI disorders do. The investigators want to learn if the Gastrointestinal Symptoms Questionnaire (GIQ) can help us tell which children with ASD also have gastrointestinal disorders.

Hypothesis 1: Children with ASD exhibit high rates of symptomatic GI dysfunction that are not identified by current diagnostic evaluation.

Hypothesis 2: Painful or discomfort-causing gastrointestinal dysfunctions contribute to an elevated incidence or severity of PB in an identifiable subpopulation of PB-expressing children. The investigators anticipate that the proposed study will raise the standard of medical care for children with ASD by improving current methods of identifying GI dysfunction and determining whether there is a significant relationship between GI dysfunction and PB in this population.

Condition or Disease Intervention/Treatment Phase
  • Other: evaluation visit by a pediatric gastroenterologist

Study Design

Study Type:
Observational
Actual Enrollment :
131 participants
Observational Model:
Cohort
Official Title:
Understanding Gastrointestinal Conditions in Children With ASD
Study Start Date :
Sep 1, 2008
Actual Primary Completion Date :
Jun 1, 2010
Actual Study Completion Date :
Feb 1, 2011

Outcome Measures

Primary Outcome Measures

  1. diagnosis of active gastrointestinal disorder/dysfunction based on the medical history reviewed by and the physical examination performed by a pediatric gastroenterologist [6 months after initial evaluation by pediatric gastroenterologist]

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children who are ATN Registry subjects between 2 and 17 years old (inclusive)

  • Meet criteria for an ASD according to the diagnostic measures Autism Diagnostic Observation Schedule (ADOS) and DSM-IV Symptom Checklist, which were conducted at an established ATN center within the last 18 months

Exclusion Criteria:
  • Diagnoses of Rett Syndrome, Childhood Disintegrative Disorder, or other genetic disorders (e.g. Fragile X, Down syndrome, etc.).

Contacts and Locations

Locations

Site City State Country Postal Code
1 LADDERS, Massachusetts General Hospital Boston Massachusetts United States 02412

Sponsors and Collaborators

  • Massachusetts General Hospital
  • Autism Speaks
  • Columbia University

Investigators

  • Principal Investigator: Harland S Winter, MD, Massachusetts General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Harland S. Winter, MD, Director, Pediatric Inflammatory Bowel Disease Center, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01675414
Other Study ID Numbers:
  • Grant 2037
First Posted:
Aug 30, 2012
Last Update Posted:
Aug 30, 2012
Last Verified:
Aug 1, 2012
Keywords provided by Harland S. Winter, MD, Director, Pediatric Inflammatory Bowel Disease Center, Massachusetts General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 30, 2012